<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Cutler, Andrew J</style></author><author><style face="normal" font="default" size="100%">Brecher, Martin</style></author><author><style face="normal" font="default" size="100%">Datto, Catherine</style></author><author><style face="normal" font="default" size="100%">Weisler, Richard H</style></author><author><style face="normal" font="default" size="100%">Suppes, Trisha</style></author><author><style face="normal" font="default" size="100%">Joyce, Meredith</style></author><author><style face="normal" font="default" size="100%">Katzman, Martin A</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Quetiapine for the Treatment of Depression Associated with Bipolar Disorder—Selected Posters</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2008-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">11-11</style></pages><abstract><style  face="normal" font="default" size="100%">Quetiapine is approved for the treatment of acute mania and depression associated with bipolar disorder, a complex and debilitating illness that has a lifetime prevalence between 1% to 4% in the US [Bowden CL et al. J Clin Psychiatry 2005]. Data from several posters showed the superiority of extended release quetiapine as a treatment for major depressive disorder and generalized anxiety disorder associated with bipolar I/II disorders versus placebo in patients aged 18 to 65 years.</style></abstract><number><style face="normal" font="default" size="100%">3</style></number><volume><style face="normal" font="default" size="100%">8</style></volume></record></records></xml>